Allspring Global Investments
XERS icon

Allspring Global Investments’s Xeris Biopharma Holdings XERS Stock Holding History

Allspring Global Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-607
Closed -$1.73K – 2439
2024
Q3 		$1.73K Sell
607
-15,675
-96% -$40.3K ﹤0.01% 2277
2024
Q2 		$36.6K Buy
16,282
+15,929
+4,512% +$32.1K ﹤0.01% 2011
2024
Q1 		$780 Buy
353
+186
+111% +$481 ﹤0.01% 2246
2023
Q4 		$392 Sell
167
-568
-77% -$1.05K ﹤0.01% 2164
2023
Q3 		$1.37K Buy
735
+168
+30% +$385 ﹤0.01% 2733
2023
Q2 		$1.49K Buy
+567
New +$1.44K ﹤0.01% 2647

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allspring Global Investments's XERS Position: Q4 2024 in Review

Allspring Global Investments sold out of Xeris Biopharma Holdings (XERS) in Q4 2024, closing a stake of 607 shares — an estimated $1.73K sold.

Allspring Global Investments first reported a position in XERS in Q2 2023 and held it in 6 quarters. The position peaked at $36.6K in Q2 2024. 162 funds tracked by Wall St. Rank hold XERS as of Q4 2024.

  • Allspring Global Investments reported no remaining Xeris Biopharma Holdings position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 607 Xeris Biopharma Holdings shares in Q4 2024, an estimated $1.73K.
  • Allspring Global Investments first reported a position in Xeris Biopharma Holdings in Q2 2023 and held it in 6 quarters.
  • Allspring Global Investments's Xeris Biopharma Holdings position peaked at $36.6K in Q2 2024.
  • 162 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.